The pharmaceuticals biotechnology sector reinforces its position as top RD investor both worldwide and in the US, accounting respectively for 18.9% and 25.0%.
Farmaatsiatoodete ja biotehnoloogia sektor kindlustab oma positsiooni suurima investeerijana nii kogu maailmas (18,9%) kui ka USAs (25,0%).